XML 31 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Note 8 - Income Taxes
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

8. Income Taxes 

 

Income (loss) before income taxes (in thousands):

 

  

Year Ended December 31,

 
  

2024

  

2023

 

Domestic

 $(53,585) $(42,210)

Foreign

      
  $(53,585) $(42,210)

 

The Company has not recorded any income tax expenses in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023.

 

The provision for income taxes differs from the amount estimated by applying the statutory federal income tax rate to income (loss) before taxes as follows:

 

  

Year Ended December 31,

 
  

2024

  

2023

 

Federal tax at statutory rate

  21.0%  21.0%

Research and development credits

  2.2   3.7 

Return to provision

  (0.3)  2.6 

Change in valuation allowance

  (21.8)  (19.1)

Deferred adjustment

     (1.6)

Change in tax rate

     (5.8)

Other

  (1.1)  (0.8)

Provision for income taxes

  %  %

 

Deferred income taxes reflect the impact of carryforwards and temporary differences between the amounts of assets and liabilities for financial reporting purposes and such amounts as measured by tax laws. The carryforwards and temporary differences, which give rise to a significant portion of the Company’s deferred tax asset (liability) as of December 31, 2024 and 2023, are as follows (in thousands):

 

  

December 31,

 
  

2024

  

2023

 

Deferred tax assets

        

Accruals

 $1,218  $1,502 

Net operating loss carryforwards

  66,952   61,072 

Tax credit carryforwards

  10,838   9,815 

Stock-based compensation

  9,588   7,704 

R&D capitalization

  10,358   7,384 

Lease liability

  1,869   1,920 

Property and equipment

  35   7 

Intangible assets

  279   99 

Gross deferred tax assets

  101,137   89,503 

Valuation allowance

  (99,542)  (87,853)

Total deferred tax assets

  1,595   1,650 
         

Deferred tax liabilities

        

Right-of-use assets

  (1,595)  (1,650)

Total deferred tax liabilities

  (1,595)  (1,650)
         

Net deferred tax assets/(liabilities)

 $  $ 

 

The Company’s unrecognized tax benefits as of  December 31, 2024 and 2023 were $17.4 million and $10.2 million, respectively. If recognized, none of the unrecognized tax benefits would impact income tax expense to the extent that the Company continues to maintain a full valuation allowance against its deferred tax assets.

 

A reconciliation of the beginning and ending amounts of unrecognized tax benefit is as follows (in thousands):

 

  

December 31,

 
  

2024

  

2023

 

Unrecognized tax benefits at beginning of year

 $10,170  $8,925 

Increases related to current year tax positions

  4,366   1,575 

Increases related to prior year tax positions

  2,993   1,129 

Decreases related to prior year tax positions

  (153)  (1,459)

Unrecognized tax benefits at end of year

 $17,376  $10,170 

 

The Company’s policy is to recognize interest and penalties related to income taxes as components of interest expense and other expense, respectively. The Company did not accrue interest and penalties related to unrecognized tax benefits as of December 31, 2024 and does not anticipate any significant change within twelve months of this reporting date.

 

The Company’s valuation allowance increased by $11.7 million in the year ended December 31, 2024 and increased by $8.1 million in the year ended December 31, 2023.

 

As of December 31, 2024, the Company had federal and state net operating loss (“NOL”) carryforwards of $250.0 million and $274.3 million, respectively, which begin to expire in 2034. Of the total federal NOL carryforward of $250.0 million, approximately $224.4 million is carried forward indefinitely but is limited to 80% of the taxable income.

 

As of December 31, 2024, the Company had approximately $9.5 million and $9.3 million of U.S. federal and California research and development (“R&D”) credits, respectively. The federal R&D credits begin to expire in 2035 and the California R&D credits have an indefinite carryforward period.

 

The Company is subject to taxation in the United States for Federal and for State, within various states in which the Company operates. All jurisdictions and tax years currently remain open for IRS and state taxing authorities’ examination. As of December 31, 2024, the Company was not under examination by the Internal Revenue Service or any state tax jurisdiction.

 

Internal Revenue Code Section 382 ownership change generally occurs if one or more stockholders or groups of stockholders who own at least 5% of our stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. We believe that we have had one or more ownership changes prior to 2018, but recently performed a Section 382 study to analyze fiscal years 2018 through 2024, and we do not believe that we have had any additional ownership changes over that period. Possible future changes in our stock ownership could result in limitations.